Burzynski Research Institute, Inc.
BZYR
$0.0579
$0.010421.90%
| Weiss Ratings | BZYR - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | BZYR - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Very Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Weak | |||
| Total Return Index | Fair | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | BZYR - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -0.02 | |||
| Price History | BZYR - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.00% | |||
| 30-Day Total Return | 16.03% | |||
| 60-Day Total Return | 28.67% | |||
| 90-Day Total Return | 60.83% | |||
| Year to Date Total Return | 86.77% | |||
| 1-Year Total Return | 136.33% | |||
| 2-Year Total Return | 65.43% | |||
| 3-Year Total Return | 131.60% | |||
| 5-Year Total Return | 426.36% | |||
| 52-Week High % Change | -24.81% | |||
| 52-Week Low % Change | 261.88% | |||
| Price | BZYR - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.08 | |||
| 52-Week Low Price | $0.02 | |||
| 52-Week Low Price (Date) | Mar 14, 2024 | |||
| 52-Week High Price (Date) | Sep 11, 2024 | |||
| Valuation | BZYR - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 7.61M | |||
| Enterprise Value | 7.61M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.01 | |||
| Earnings Per Share Growth | 23.33% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | -289.50 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $0.06 | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | -5.23 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | BZYR - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 131.45M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | BZYR - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 713 335 5697 | |||
| Address | 9432 Katy Freeway Houston, TX 77055 | |||
| Website | propcitweb.ddns.net:83 | |||
| Country | United States | |||
| Year Founded | 1984 | |||
| Profitability | BZYR - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | BZYR - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -107,073.53% | |||
| Return on Equity | -- | |||
| Income Statement | BZYR - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -- | |||
| EBIT (TTM) | -1.46M | |||
| Net Income (TTM) | -1.46M | |||
| Net Income Avl. to Common (TTM) | -1.46M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | 18.66% | |||
| EPS Diluted (TTM) | -0.01 | |||
| EPS Diluted Growth (Q YOY) | 18.18% | |||
| Balance Sheet | BZYR - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 600.00 | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 700.00 | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -21.30K | |||
| Current Ratio (Q) | 0.032 | |||
| Book Value Per Share (Q) | $0.00 | |||
| Total Assets (Q) | 700.00 | |||
| Total Current Liabilities (Q) | 22.00K | |||
| Total Debt (Q) | 0.00 | |||
| Total Liabilities (Q) | 22.00K | |||
| Total Common Equity (Q) | -21.30K | |||
| Cash Flow | BZYR - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -- | |||
| Cash from Financing (TTM) | 479.00K | |||
| Net Change in Cash (TTM) | -300.00 | |||
| Levered Free Cash Flow (TTM) | -479.30K | |||
| Cash from Operations (TTM) | -479.30K | |||
